Corporate news

Duesseldorf, February 18, 2021 – At its meeting yesterday, the Supervisory Board of Gerresheimer AG extended the contract with CEO Dietmar Siemssen…

Transformation into a growth value as innovation leader and solution provider Gerresheimer presents strategy process formula G as an engine towards…

Third quarter on schedule Group revenues EUR 349m; 2.1% organic revenue growth in core business Adjusted EBITDA increases by 4.1% to EUR 75m S…

Duesseldorf, October 08, 2020—Gerresheimer AG has signed a promissory loan agreement for a total of EUR 325m. The transaction with an initial issue…

Implementation of growth strategy beginning to deliver results Group revenues increase to EUR 363m with 4.6% organic growth in core business 6.9%…

Duesseldorf, June 24, 2020—Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG. “In…

Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers The CEOs of…

Duesseldorf, May 04, 2020—Gerresheimer AG will hold its planned Annual General Meeting on June 24, 2020 as a virtual annual general meeting. This has…

Stable business model as key supplier to pharma and healthcare industry Gerresheimer sustains growth path. Revenue guidance for 2020 in the mid…